Tag Archives: Adamis Pharma

Analysts Are Bullish on Top Healthcare Stocks: Adamis Pharma (ADMP), TG Therapeutics (TGTX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adamis Pharma (NASDAQ:ADMP) and TG Therapeutics (NASDAQ:TGTX) with bullish sentiments. Adamis Pharma (ADMP) In a report issued on August 10, Andrew D’silva

Maxim Group Maintains Their Buy Rating on Adamis Pharma

Maxim Group analyst Jason McCarthy maintained a Buy rating on Adamis Pharma (NASDAQ: ADMP) today and set a price target of $10. The company’s shares opened today at $3.80. McCarthy noted: “Adamis reported 1Q18 with revenue of $3.2M from the

Adamis Pharma Gets a Buy Rating from B.Riley FBR

In a report released today, Andrew D’silva from B.Riley FBR maintained a Buy rating on Adamis Pharma (NASDAQ: ADMP), with a price target of $6.25. The company’s shares closed yesterday at $3.50. D’silva wrote: “We are updating our model on

Adamis Pharma Received its Third Buy in a Row

After Maxim Group and Raymond James assigned a Buy rating to Adamis Pharma in the last month, the company received another Buy, this time from B.Riley FBR. Analyst Andrew D’silva maintained a Buy rating on Adamis Pharma (NASDAQ: ADMP) today

Maxim Group Thinks Adamis Pharma’s Stock is Going to Recover

In a report released today, Jason Kolbert from Maxim Group assigned a Buy rating to Adamis Pharma (NASDAQ: ADMP), with a price target of $5. The company’s shares opened today at $3.55, close to its 52-week low of $3.20. Kolbert

Adamis Pharma Receives a Buy from B.Riley FBR

B.Riley FBR analyst Andrew D’silva maintained a Buy rating on Adamis Pharma (NASDAQ: ADMP) today and set a price target of $9.50. The company’s shares closed yesterday at $4.65. D’silva commented: “ADMP filed its 10Q for 3Q17 AMC on Tuesday,